Clinical Trial Update: A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating recombinant von Willebrand factor (rVWF) with or without ADVATE in children with severe von Willebrand disease is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• ADVATE (antihemophilic factor VIII)
• rVWF (recombinant von Willebrand factor) (recombinant von Willebrand factor)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Von Willebrand Disease | Phase 3 | Status: RECRUITING